Cerevel Therapeutics Holdings, Inc. Quarterly Return On Equity in % from Q4 2020 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Return On Equity for the quarter ending March 31, 2024 was -98.9 %, a 28.2% decline year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2023 was -100 %, a 49.5% decline from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2022 was -67 %, a 36.9% decline from 2021.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2021 was -48.9 %, a 66.6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -98.9 -21.8 -28.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -100 -33.2 -49.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -99.7 -40.8 -69.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -83.2 -31.9 -62.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -77.2 -29.2 -60.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -67 -18.1 -36.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -58.9 -10.5 -21.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -51.3 +18 +26% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48 +34.4 +41.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -48.9 +97.5 +66.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -48.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -69.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 -82.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -146 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.